Abstract BackgroundDefine the effectiveness of a topical non-steroidal anti-inflammatory drug (NSAID) added to topical steroid use after uncomplicated phacoemulsification for the prevention of pseudophakic cystoid macular edema (PCME) using a prospective, randomized, double-masked, placebo-controlled clinical study. MethodsEyes (1000) were randomized to placebo (497) or nepafenac 0.3�503) used once daily, post-operatively for 5 weeks at two ophthalmology clinics. Diagnosis of PCME was made by clinical, ocular coherence tomography (OCT), and with fluorescein angiography confirmation. Correlation of PCME to NSAID use and the presence of pre-operative risk factors for PCME were assessed including, contralateral PCME, diabetic retinopathy, retinal vein occlusion, macular hole, epiretinal membrane, macular degeneration, retinal detachment repair, and prostaglandin use. ResultsPCME was the most common complication associated with routine cataract surgery (4.2�ith PCME risk factors, 2.0�ith risk factors excluded). Topical nepafenac 0.3�ignificantly reduces the incidence of PCME compared to placebo when used after routine cataract surgery (p = .0001). When patients with pre-operative risk factors are excluded, the incidence of PCME between treatment and placebo groups is equivalent (p = 0.31). PCME relative risk (RR) was most significant in contralateral PCME (RR 19.5), diabetic retinopathy (RR 13.1), retinal vein occlusion (RR 12.9), macular hole (RR 7.7), and epiretinal membrane (RR 5.7). Prostaglandin use and previous retinal detachment were not shown to increase risk. ConclusionPseudophakic cystoid macular edema is common after phacoemulsification cataract surgery. Topical nepafenac 0.3�educes PCME in patients with pre-operative risk factors for PCME compared to placebo but shows no benefit in patients without pre-operative risk factors. Trial registrationNIH ClincalTrials.gov retrospectively registered January 15, 2017, NCT03025945.
tomography          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/X-ray_computed_tomography

cystoid macular edema         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_edema         

diabetic retinopathy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

relative risk                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

retinal vein occlusion        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_retinal_vein_occlusion

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

placebo                       0.9999999999483862^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

contralateral                 0.9999999957465207^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

retinal vein occlusion        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_retinal_vein_occlusion

incidence                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incidence_(epidemiology)

fluorescein angiography       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Fluorescein_angiography

retinal detachment            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retinal_detachment    

phacoemulsification           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phacoemulsification   

phacoemulsification           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phacoemulsification   

placebo                       0.9999999999483862^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

topical steroid               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Topical_steroid       

epiretinal membrane           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Epiretinal_membrane   

non-steroidal anti-inflammatory drug1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

prostaglandin                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prostaglandin         

cystoid macular edema         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_edema         

incidence                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incidence_(epidemiology)

NSAID                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

ophthalmology                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ophthalmology         

diabetic retinopathy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

retinal detachment            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retinal_detachment    

macular hole                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_hole          

epiretinal membrane           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Epiretinal_membrane   

placebo                       0.9999999999483862^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

macular hole                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_hole          

NSAID                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

contralateral                 0.9999999957465207^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

placebo                       0.9999999999483862^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

macular degeneration          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_degeneration  

pseudophakic                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intraocular_lens      

